Detailed Information on Publication Record
2015
Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues
HUSER, Martin, Lenka ŠMARDOVÁ, Petr JANKŮ, Igor CRHA, Jana ŽÁKOVÁ et. al.Basic information
Original name
Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues
Authors
HUSER, Martin (203 Czech Republic, guarantor, belonging to the institution), Lenka ŠMARDOVÁ (203 Czech Republic, belonging to the institution), Petr JANKŮ (203 Czech Republic, belonging to the institution), Igor CRHA (203 Czech Republic, belonging to the institution), Jana ŽÁKOVÁ (203 Czech Republic, belonging to the institution), Petr ŠTOURAČ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Pavel VENTRUBA (203 Czech Republic, belonging to the institution)
Edition
Journal of Assisted Reproduction and Genetics, New York, Springer, 2015, 1058-0468
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30214 Obstetrics and gynaecology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.858
RIV identification code
RIV/00216224:14110/15:00083094
Organization unit
Faculty of Medicine
UT WoS
000360547300006
Keywords in English
Chemotherapy; Hodgkin lymphoma; Gonadotropin-releasing hormone analogues; Fertility; Pregnancy
Tags
Tags
International impact, Reviewed
Změněno: 28/4/2016 13:22, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
Purpose Aim of this prospective observational study was to analyze fertility status of Hodgkin lymphoma (HL) patients treated with different types of chemotherapy while receiving GnRH analogues to preserve ovarian function. Methods Fertility status was assessed among 108 females in reproductive age treated by curative chemotherapy for freshly diagnosed HL between 2005 and 2010 in university-based tertiary fertility and oncology center. All patients received GnRH analogues during chemotherapy to preserve their ovarian function. Their reproductive functions were assessed by follicle-stimulating hormone (FSH) measurement and pregnancy achievement. Ovarian function was determined separately in three groups with increasing gonadotoxicity of chemotherapy.